There was no significant difference between plasma levels of inflammatory biomarkers (hsCRP, MCP-1, sVCAM-1 and sICAM-1) and BUCVR in patients with or without the following comorbidities: diabetes, obesity, hypertension, dyslipidemia, history of CVD and smoking. This evidence concerns the gene CCL2 and metabolic syndrome.